Tukysa + Standard Care Improves Survival for HER2+ Brain Mets

moderators
Posts: 6,955
Tukysa Plus Standard Care Improves Survival in People With HER2-Positive Brain Mets
Feb 27, 2023
Tukysa plus the standard of care improved survival in people diagnosed with metastatic, HER2-positive breast cancer that had spread to the brain. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.
New Feature: Fill out your Profile to share more about you. Learn more...